These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 8875767)
21. Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756. Bell JM; Turnidge JD; Jones RN; Int J Antimicrob Agents; 2002 Feb; 19(2):125-32. PubMed ID: 11850165 [TBL] [Abstract][Full Text] [Related]
22. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN; J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [TBL] [Abstract][Full Text] [Related]
23. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Hoban D; Felmingham D J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. Reynolds R; Shackcloth J; Felmingham D; MacGowan A; J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases. Suzuki K; Fujisawa T; Nakashima M; Hamasaki R J Infect Chemother; 2005 Oct; 11(5):253-5. PubMed ID: 16258823 [TBL] [Abstract][Full Text] [Related]
26. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA; Ehrhardt AF; Jones RN Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. Powell M; McVey D; Kassim MH; Chen HY; Williams JD J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856 [TBL] [Abstract][Full Text] [Related]
28. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996. Felmingham D; Washington J J Chemother; 1999 Feb; 11 Suppl 1():5-21. PubMed ID: 10207769 [TBL] [Abstract][Full Text] [Related]
29. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance patterns among respiratory pathogens at a German university children's hospital over a period of 10 years. Arri SJ; Fluegge K; Mueller U; Berner R Eur J Pediatr; 2006 Jan; 165(1):9-13. PubMed ID: 16133241 [TBL] [Abstract][Full Text] [Related]
31. [Recent trend of incidence of respiratory pathogenic bacteria and its susceptibility to antimicrobial agents: studies in the year 1984-1986]. Nishioka K; Ogiwara H; Ida S; Takishima T Jpn J Antibiot; 1988 Sep; 41(9):1212-22. PubMed ID: 3149325 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program. Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464 [TBL] [Abstract][Full Text] [Related]
33. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Thornsberry C; Ogilvie PT; Holley HP; Sahm DF Antimicrob Agents Chemother; 1999 Nov; 43(11):2612-23. PubMed ID: 10543737 [TBL] [Abstract][Full Text] [Related]
34. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007]. Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709 [TBL] [Abstract][Full Text] [Related]
35. Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Naaber P; Tamm E; Pütsepp A; Kõljalg S; Maimets M Clin Microbiol Infect; 2000 Dec; 6(12):675-7. PubMed ID: 11284928 [No Abstract] [Full Text] [Related]
36. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections. Bantar C; Nicola F; Fernandez Canigia L; Arenoso HJ; Soutric J; Montoto M; Blanco M; Smayevsky J; Jasovich A J Chemother; 2000 Jun; 12(3):223-7. PubMed ID: 10877517 [TBL] [Abstract][Full Text] [Related]
37. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Pfaller MA; Farrell DJ; Sader HS; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951 [TBL] [Abstract][Full Text] [Related]
38. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance. Richard MP; Aguado AG; Mattina R; Marre R J Antimicrob Chemother; 1998 Feb; 41(2):207-14. PubMed ID: 9533462 [TBL] [Abstract][Full Text] [Related]
39. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967 [TBL] [Abstract][Full Text] [Related]
40. Epidemiology of major respiratory pathogens. Debbia EA; Schito GC; Zoratti A; Gualco L; Tonoli E; Marchese A J Chemother; 2001 Nov; 13 Spec No 1(1):205-10. PubMed ID: 11936367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]